Search

Sagar S. Patel

Examiner (ID: 15778, Phone: (571)272-1317 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1626
Total Applications
657
Issued Applications
436
Pending Applications
84
Abandoned Applications
159

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18647757 [patent_doc_number] => 20230293528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS [patent_app_type] => utility [patent_app_number] => 17/975939 [patent_app_country] => US [patent_app_date] => 2022-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48738 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975939 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/975939
Ruxolitinib formulation for reduction of itch in atopic dermatitis Oct 27, 2022 Issued
Array ( [id] => 18323920 [patent_doc_number] => 20230122048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => PHARMACEUTICAL COMBINATION OF AN EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF TUMOURS [patent_app_type] => utility [patent_app_number] => 17/973714 [patent_app_country] => US [patent_app_date] => 2022-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11967 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17973714 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/973714
Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours Oct 25, 2022 Issued
Array ( [id] => 18282617 [patent_doc_number] => 20230098089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => MULTI-ARM SINGLE MOLECULAR WEIGHT POLYETHYLENE GLYCOL ACTIVE DERIVATIVE AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/047454 [patent_app_country] => US [patent_app_date] => 2022-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047454 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047454
Multi-arm single molecular weight polyethylene glycol active derivative and application thereof Oct 17, 2022 Issued
Array ( [id] => 19629651 [patent_doc_number] => 20240408100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => TREATMENT METHODS FOR SUBJECTS HAVING CANCER WITH A DYSREGULATED MAPK AND/OR PI3K PATHWAY [patent_app_type] => utility [patent_app_number] => 18/699669 [patent_app_country] => US [patent_app_date] => 2022-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18694 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18699669 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/699669
TREATMENT METHODS FOR SUBJECTS HAVING CANCER WITH A DYSREGULATED MAPK AND/OR PI3K PATHWAY Oct 12, 2022 Pending
Array ( [id] => 19613073 [patent_doc_number] => 20240398753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => METHOD FOR PRODUCING LIQUID MIXTURE, LIQUID MIXTURE, AND SOLID COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/699647 [patent_app_country] => US [patent_app_date] => 2022-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12826 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18699647 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/699647
METHOD FOR PRODUCING LIQUID MIXTURE, LIQUID MIXTURE, AND SOLID COMPOSITION Oct 10, 2022 Pending
Array ( [id] => 19556318 [patent_doc_number] => 20240368110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => PROCESS FOR PURIFYING MESO-LACTIDE [patent_app_type] => utility [patent_app_number] => 18/689533 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18689533 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/689533
PROCESS FOR PURIFYING MESO-LACTIDE Sep 8, 2022 Pending
Array ( [id] => 20143906 [patent_doc_number] => 12378233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Immunomodulating azalides [patent_app_type] => utility [patent_app_number] => 17/929777 [patent_app_country] => US [patent_app_date] => 2022-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 58668 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 554 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929777 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/929777
Immunomodulating azalides Sep 5, 2022 Issued
Array ( [id] => 18522907 [patent_doc_number] => 20230233557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/930015 [patent_app_country] => US [patent_app_date] => 2022-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44062 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930015 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/930015
FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS Sep 5, 2022 Abandoned
Array ( [id] => 19584889 [patent_doc_number] => 20240382446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => METHOD FOR IMPROVING FEED INTAKE [patent_app_type] => utility [patent_app_number] => 18/686681 [patent_app_country] => US [patent_app_date] => 2022-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18686681 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/686681
METHOD FOR IMPROVING FEED INTAKE Aug 31, 2022 Pending
Array ( [id] => 19430888 [patent_doc_number] => 20240299386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => Novel imidazole derivatives having protein kinase inhibitory activity and uses thereof [patent_app_type] => utility [patent_app_number] => 18/571331 [patent_app_country] => US [patent_app_date] => 2022-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13770 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571331 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/571331
Novel imidazole derivatives having protein kinase inhibitory activity and uses thereof Aug 15, 2022 Pending
Array ( [id] => 20254867 [patent_doc_number] => 12427200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-30 [patent_title] => Compositions and methods for the treatment of viral infections [patent_app_type] => utility [patent_app_number] => 17/887776 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 149 [patent_figures_cnt] => 216 [patent_no_of_words] => 178391 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17887776 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/887776
Compositions and methods for the treatment of viral infections Aug 14, 2022 Issued
Array ( [id] => 19528087 [patent_doc_number] => 20240351989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF [patent_app_type] => utility [patent_app_number] => 18/682361 [patent_app_country] => US [patent_app_date] => 2022-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9181 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682361 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/682361
PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF Aug 7, 2022 Pending
Array ( [id] => 18344901 [patent_doc_number] => 20230133011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES [patent_app_type] => utility [patent_app_number] => 17/816980 [patent_app_country] => US [patent_app_date] => 2022-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9103 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816980 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/816980
MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES Aug 1, 2022 Pending
Array ( [id] => 18036131 [patent_doc_number] => 20220380346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => 2,3-DIHYDRO-ISOINDOLE-1-ON DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME [patent_app_type] => utility [patent_app_number] => 17/871458 [patent_app_country] => US [patent_app_date] => 2022-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871458 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/871458
2,3-DIHYDRO-ISOINDOLE-1-ON DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Jul 21, 2022 Abandoned
Array ( [id] => 18830781 [patent_doc_number] => 20230399305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-14 [patent_title] => PROCESS FOR PREPARING HIGH-DENSITY QUERCETIN [patent_app_type] => utility [patent_app_number] => 17/859656 [patent_app_country] => US [patent_app_date] => 2022-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11304 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17859656 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/859656
Process for preparing high-density quercetin Jul 6, 2022 Issued
Array ( [id] => 18298439 [patent_doc_number] => 20230108125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => SMALL MOLECULE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/849600 [patent_app_country] => US [patent_app_date] => 2022-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33321 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 592 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849600 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/849600
SMALL MOLECULE COMPOUNDS Jun 24, 2022 Abandoned
Array ( [id] => 18309136 [patent_doc_number] => 20230113036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE [patent_app_type] => utility [patent_app_number] => 17/807245 [patent_app_country] => US [patent_app_date] => 2022-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17807245 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/807245
Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance Jun 15, 2022 Issued
Array ( [id] => 17929747 [patent_doc_number] => 20220324872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => CDK2/4/6 Inhibitors [patent_app_type] => utility [patent_app_number] => 17/841138 [patent_app_country] => US [patent_app_date] => 2022-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17841138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/841138
CDK2/4/6 Inhibitors Jun 14, 2022 Abandoned
Array ( [id] => 18698607 [patent_doc_number] => 20230329090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => SPIRO COMPOUND AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/020916 [patent_app_country] => US [patent_app_date] => 2022-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 265 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020916 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/020916
SPIRO COMPOUND AND APPLICATION THEREOF Jun 10, 2022 Pending
Array ( [id] => 20715264 [patent_doc_number] => 12630498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-19 [patent_title] => Arylamides and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/832384 [patent_app_country] => US [patent_app_date] => 2022-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30062 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832384 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/832384
Arylamides and methods of use thereof Jun 2, 2022 Issued
Menu